{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:10:40Z","timestamp":1779923440123,"version":"3.53.1"},"reference-count":0,"publisher":"CMA Joule Inc.","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Medical Association Journal"],"published-print":{"date-parts":[[2006,6,20]]},"DOI":"10.1503\/cmaj.050658","type":"journal-article","created":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T21:59:49Z","timestamp":1150754389000},"page":"1835-1835","source":"Crossref","is-referenced-by-count":11,"title":["Buprenorphine: a potential new treatment option for opioid dependence"],"prefix":"10.1503","volume":"174","author":[{"given":"A.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"382","container-title":["Canadian Medical Association Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1503\/cmaj.050658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T16:52:55Z","timestamp":1552927975000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cmaj.ca\/cgi\/doi\/10.1503\/cmaj.050658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,20]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2006,6,20]]}},"URL":"https:\/\/doi.org\/10.1503\/cmaj.050658","relation":{},"ISSN":["0820-3946","1488-2329"],"issn-type":[{"value":"0820-3946","type":"print"},{"value":"1488-2329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,20]]}}}